Immune-Onc Therapeutics, Inc.
Biotechnology company · Palo Alto, California, United States
Immune-Onc Therapeutics, Inc. is a biotechnology company headquartered in Palo Alto, California, United States. Its earliest recorded incorporation is in 2015. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2.1 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $7 million sold in a notice filed in 2016.
Immune-Onc Therapeutics at a glance
What does Immune-Onc Therapeutics do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2.1 million in total (2020). NIH funding came from the National Cancer Institute.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $7 million sold (2016).
Frequently asked questions about Immune-Onc Therapeutics
Where is Immune-Onc Therapeutics headquartered?
Immune-Onc Therapeutics, Inc. is headquartered in Palo Alto, California, United States.
What does Immune-Onc Therapeutics do?
Immune-Onc Therapeutics, Inc. is a biotechnology company.
When was Immune-Onc Therapeutics founded?
The earliest incorporation on record for Immune-Onc Therapeutics, Inc. is in 2015, according to public company registers.
Similar companies
- Exai Bio Inc.Palo Alto, California, United States
- Kodiak Sciences Inc.Palo Alto, California, United States
- Scilex Holding CoPalo Alto, California, United States
- Greenstone Biosciences, Inc.Palo Alto, California, United States
- Combinati IncPalo Alto, California, United States
- Eiger BioPharmaceuticals, Inc.Palo Alto, California, United States
- Riboscience LLCPalo Alto, California, United States
- Irenix Medical, Inc.Palo Alto, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences